Company profile: Colorcon
1.1 - Company Overview
Company description
- Provider of specialty excipients, film coatings (immediate, enteric, sustained release), and functional packaging for solid oral dosage forms in pharmaceutical, nutritional, and animal health markets. Provides formulation support to enhance adherence, reduce medication errors, and add brand value. Products include Opadry, Acryl-EZE, Surelease, Starch 1500, METHOCEL, and StarTab, plus label-friendly solutions for dietary supplements.
Products and services
- Film Coatings: supplies a range of pharma-grade film coatings engineered for immediate, enteric, and sustained release, including Opadry®, Acryl-EZE®, and Surelease®, for solid oral dosage forms in pharmaceutical applications
- Core Excipients: fabricates compendial-grade excipients for tablets, capsules, and multiparticulates, including Starch 1500®, METHOCEL™, and StarTab®, supporting formulation of solid oral dosage products
- Pharmaceuticals: delivers custom-engineered support to develop medicines that enhance patient adherence, reduce medication errors, and add value to pharmaceutical brands.
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Colorcon
Veristat
HQ: United Kingdom
Website
- Description: Provider of full-service, science-focused CRO support for pharmaceutical, biotechnology, and medical device companies, with 20+ years of experience in clinical trials and regulatory submissions. Services include clinical operations, project management, monitoring and site management, patient recruitment and retention (including an in-house call center), and medical safety across global trials.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Veristat company profile →
Multi-Specialty Research Associates
HQ: United States
Website
- Description: Provider of Phase I-IV clinical trial services across a wide range of therapeutic areas, including vaccine research for Covid-19 and other infectious diseases, delivered from its north Florida office and backed by more than 50 years of combined research experience.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Multi-Specialty Research Associates company profile →
Pearl Pathways
HQ: United States
Website
- Description: Provider of life science product development and life-saving devices, diagnostics, and therapeutic products.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Pearl Pathways company profile →
Orgenesis
HQ: United States
Website
- Description: Provider of point-of-care platforms, technologies, and networks to develop, produce, and distribute advanced cell and gene therapies, including a novel diabetes treatment that converts liver cells into functional insulin-producing cells. Offers POCare Platform, Therapies, Technologies, and a global POCare Network to lower costs and accelerate market access.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Orgenesis company profile →
Cognate BioServices
HQ: United States
Website
- Description: Provider of fully integrated contract bioservices, offering full development and cGMP manufacturing services to companies and institutions developing cell-based products. Delivers comprehensive cell and gene therapy CDMO solutions, including development and manufacturing for cell- and gene-mediated cell therapies.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Cognate BioServices company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Colorcon
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Colorcon
2.2 - Growth funds investing in similar companies to Colorcon
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Colorcon
4.2 - Public trading comparable groups for Colorcon
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →